As of 2025-05-10, the Intrinsic Value of Raffles Medical Group Ltd (BSL.SI) is 0.75 SGD. This BSL.SI valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.04 SGD, the upside of Raffles Medical Group Ltd is -27.70%.
The range of the Intrinsic Value is 0.51 - 1.80 SGD
Based on its market price of 1.04 SGD and our intrinsic valuation, Raffles Medical Group Ltd (BSL.SI) is overvalued by 27.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.51 - 1.80 | 0.75 | -27.7% |
| DCF (Growth 10y) | 0.62 - 2.15 | 0.91 | -12.7% |
| DCF (EBITDA 5y) | 0.58 - 0.94 | 0.76 | -27.3% |
| DCF (EBITDA 10y) | 0.65 - 1.08 | 0.85 | -18.7% |
| Fair Value | 0.26 - 0.26 | 0.26 | -75.10% |
| P/E | 0.74 - 0.99 | 0.88 | -15.6% |
| EV/EBITDA | 0.60 - 0.98 | 0.79 | -23.7% |
| EPV | 1.72 - 2.53 | 2.13 | 104.7% |
| DDM - Stable | 0.35 - 1.81 | 1.08 | 4.1% |
| DDM - Multi | 0.53 - 1.94 | 0.81 | -22.1% |
| Market Cap (mil) | 1,959.92 |
| Beta | 0.34 |
| Outstanding shares (mil) | 1,884.54 |
| Enterprise Value (mil) | 1,809.26 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.09% |
| Cost of Debt | 4.25% |
| WACC | 6.73% |